What is the pathophysiology of Hemolysis, Elevated Liver enzymes, and Low Platelet count (HELLP) syndrome and its relation to eclampsia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Pathophysiology of HELLP Syndrome and Its Relationship to Eclampsia

HELLP syndrome results from inadequate placental perfusion that progresses to endothelial dysfunction, causing a cascade of pathological processes including microangiopathic hemolytic anemia and hepatic sinusoidal obstruction, which represents a severe manifestation on the spectrum of preeclampsia-related disorders. 1

Pathophysiology of HELLP Syndrome

Initial Trigger and Placental Factors

  • HELLP syndrome begins with inadequate placental perfusion due to defective arterial placental perfusion 1
  • The placenta releases vasoactive substances including:
    • Nitric oxide
    • Prostaglandins
    • Endothelin
  • These substances trigger a cascade of events that affect multiple organ systems 1

Endothelial Dysfunction and Vascular Changes

  • The released placental factors induce:
    • Platelet aggregation
    • Endothelial dysfunction
    • Arterial hypertension 1
  • Endothelial damage leads to fibrin release, forming cross-linked networks in small blood vessels 1
  • This process results in microangiopathic hemolytic anemia - the "H" (hemolysis) in HELLP 1

Hepatic Involvement

  • Fibrin deposition within hepatic sinusoids causes sinusoidal obstruction 1
  • This leads to hepatic ischemia - explaining the "EL" (elevated liver enzymes) in HELLP 1
  • Potential severe complications include:
    • Subcapsular hematomas
    • Parenchymal hemorrhage
    • Hepatic rupture (a life-threatening complication) 1, 2

Hematological Changes

  • Consumption of circulating platelets in microthrombi formation leads to thrombocytopenia - the "LP" (low platelets) in HELLP 1, 3
  • Activation of coagulation and complement systems occurs 3
  • In approximately 50% of women with HELLP, activation of coagulation factors and platelets can precipitate disseminated intravascular coagulation (DIC) 3

Relationship Between HELLP Syndrome and Eclampsia

Spectrum of Disease

  • Preeclampsia represents a spectrum of pathophysiological changes 1
  • HELLP syndrome exists at the most severe end of this spectrum 1
  • Eclampsia is defined as preeclampsia plus seizures 1

Overlapping Features

  • HELLP syndrome occurs in 0.2-0.6% of pregnancies 1
  • It can coexist with preeclampsia in 70-80% of cases 3
  • Overlapping clinical features of preeclampsia are present in many patients with HELLP syndrome 1
  • Both conditions share the common pathophysiological pathway of endothelial dysfunction 1, 3

Key Differences

  • HELLP syndrome can occur in patients with normal blood pressure (15% of cases) 1
  • HELLP syndrome shows more extensive gene derangement in third-trimester placentas compared to preeclampsia 3
  • The inflammatory response is stronger in HELLP syndrome than in preeclampsia 3
  • Fetal messenger RNAs in maternal blood at 15-20 weeks gestation are significantly more abnormal in HELLP than in preeclampsia, suggesting a more extensive placental insult 3

Timing and Progression

  • Most cases of HELLP occur between weeks 27 and 37 of gestation 1
  • Approximately 20% of HELLP cases occur within 48 hours after delivery 1
  • The progression from preeclampsia to eclampsia and/or HELLP syndrome can be rapid and unpredictable 4, 5

Clinical Implications and Management

  • Prompt delivery is the definitive treatment for both eclampsia and HELLP syndrome 1, 2
  • For eclampsia: delivery as soon as possible after maternal stabilization, regardless of gestational age 2
  • For HELLP: expeditious delivery after maternal coagulopathy and severe hypertension have been corrected 2
  • Reduction in the time interval between diagnosis and delivery correlates with better maternal and fetal outcomes 6
  • Abdominal imaging should be performed in suspected HELLP to rule out hepatic complications 1

Pitfalls and Caveats

  1. Delayed diagnosis: HELLP syndrome may be misdiagnosed as other conditions such as acute cholecystitis, drug reaction, or idiopathic thrombocytopenia 1

  2. Postpartum presentation: HELLP can develop or worsen after delivery, requiring continued vigilance in the postpartum period 5

  3. Rapid deterioration: The condition can progress rapidly to life-threatening complications including DIC, acute renal failure, and hepatic rupture 3, 5

  4. Laboratory monitoring: Resolution of laboratory abnormalities follows a protracted course over several days after delivery, with platelet counts typically normalizing before liver enzymes 4

  5. Hemolysis vs. hemorrhage: Differentiation between a rapid drop in hemoglobin due to hemolysis versus postpartum hemorrhage can be challenging in HELLP syndrome 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Eclampsia and HELLP Syndrome

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Pathogenesis of the syndrome of hemolysis, elevated liver enzymes, and low platelet count (HELLP): a review.

European journal of obstetrics, gynecology, and reproductive biology, 2013

Research

[Clinical and chemical laboratory course of HELLP syndrome--a retrospective analysis].

Zeitschrift fur Geburtshilfe und Neonatologie, 1996

Research

[Obstetric management of patients with HELLP syndrome].

Zeitschrift fur Geburtshilfe und Perinatologie, 1993

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.